Literature DB >> 1686396

Acute extrapyramidal syndromes in neuroleptic-treated elders: a pilot study.

L Ganzini1, R Heintz, W F Hoffman, G A Keepers, D E Casey.   

Abstract

The incidence, morbidity, and risk factors for acute extrapyramidal syndromes (EPS) such as akathisia and drug-induced parkinsonism (DIP) in neuroleptic-treated elders have not been systematically explored. This study presents data on 17 elderly patients who were prospectively examined for up to 4 weeks for acute EPS, functional and cognitive status, and behavioral disturbances. Seventy-one percent of subjects developed DIP, and 18% developed akathisia. Predictors of DIP included pre-neuroleptic treatment parkinsonian signs and neuroleptic dose, despite use of low doses of neuroleptics. Development of acute EPS was associated with failure to improve behaviorally. New-onset urinary incontinence was the most common functional abnormality.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1686396     DOI: 10.1177/089198879100400408

Source DB:  PubMed          Journal:  J Geriatr Psychiatry Neurol        ISSN: 0891-9887            Impact factor:   2.680


  5 in total

1.  Drug-induced parkinsonism.

Authors:  Frandy Susatia; Hubert H Fernandez
Journal:  Curr Treat Options Neurol       Date:  2009-05       Impact factor: 3.598

Review 2.  Drug-induced movement disorders.

Authors:  F J Jiménez-Jiménez; P J García-Ruiz; J A Molina
Journal:  Drug Saf       Date:  1997-03       Impact factor: 5.606

3.  Antipsychotic-induced extrapyramidal syndromes in psychiatric practice: a case-control study.

Authors:  I Schillevoort; R M C Herings; G W K Hugenholtz; A de Boer; W A Nolen; R A C Roos; H G M Leufkens
Journal:  Pharm World Sci       Date:  2005-08

Review 4.  Drug-induced depression in the aged. What can be done?

Authors:  L Ganzini; J R Walsh; S B Millar
Journal:  Drugs Aging       Date:  1993 Mar-Apr       Impact factor: 3.923

Review 5.  Antipsychotics in older patients. A safety perspective.

Authors:  B G Pollock; B H Mulsant
Journal:  Drugs Aging       Date:  1995-04       Impact factor: 3.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.